What does APOTHEEK BURMS do?

APOTHEEK BURMS is a pharmacy in Lede. Public Limited, started on 14 October 1992, 1 establishment.

What is the address of APOTHEEK BURMS?

The registered office of APOTHEEK BURMS is located at Markt 35, 9340 Lede.

Is APOTHEEK BURMS still active?

Yes. According to the CBE (30 October 2026) APOTHEEK BURMS is active, legal situation “Normale toestand”, started on 14 October 1992.

Is APOTHEEK BURMS registered on Peppol?

Yes, APOTHEEK BURMS is registered on the Peppol network with ID 0208:0448549180.

What is the enterprise number of APOTHEEK BURMS?

The enterprise number of APOTHEEK BURMS is BE0448549180.

When was APOTHEEK BURMS founded?

APOTHEEK BURMS was founded on 14 October 1992.

Who are the directors of APOTHEEK BURMS?

According to the 2025 annual accounts, the directors of APOTHEEK BURMS are: FARMAS NV.

Is APOTHEEK BURMS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 October 1992; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK BURMS make in 2025?

APOTHEEK BURMS posted a profit after taxes of € 36,121 in financial year 2025.

What is the revenue of APOTHEEK BURMS?

As a small company, APOTHEEK BURMS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 86,378.

How many employees does APOTHEEK BURMS have?

According to the 2025 annual accounts, APOTHEEK BURMS has 0.2 full-time equivalents (FTE).

APOTHEEK BURMS (Public Limited) - Lede - BE0448549180

Dossier APOTHEEK BURMS, printed on 30 October 2026 from databakkes.be/en/0448549180/apotheek-burms. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 0.8 to 0.2.

Financials

Financial year 2025

APOTHEEK BURMS from Lede, company number BE0448549180, closed financial year 2025 with a result of € 36,121 after tax. For that financial year APOTHEEK BURMS recorded a gross margin of € 86,378 and equity of € 145,693. Compared with financial year 2024, the result moved from € 39,571 to € 36,121. The company is profitable. The buffer shrank hard: equity is 54 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 12, 2026.

What it is worth Shrank hard

€ 145,693

▼ 54% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 36,121

▼ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 58,182

▲ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 210,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

0.2

▼ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 29,367

▼ 46% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,287

▲ 98% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 62,319

▼ 6% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 54,335

▼ 27% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,516

▼ 84% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 98,488 Gross margin 2022: € 98,488 First fiscal year in the series	€ 114,382 Gross margin 2023: € 114,382 ▲ 16% vs 2022 (€ 98,488) Favourable step	€ 115,649 Gross margin 2024: € 115,649 ▲ 1% vs 2023 (€ 114,382) Favourable step	€ 86,378 Gross margin 2025: € 86,378 ▼ 25% vs 2024 (€ 115,649) Unfavourable step	▼ 25%
Profit after taxes	€ 28,666 Profit after taxes 2022: € 28,666 First fiscal year in the series	€ 29,383 Profit after taxes 2023: € 29,383 ▲ 2% vs 2022 (€ 28,666) Favourable step	€ 39,571 Profit after taxes 2024: € 39,571 ▲ 35% vs 2023 (€ 29,383) Favourable step	€ 36,121 Profit after taxes 2025: € 36,121 ▼ 9% vs 2024 (€ 39,571) Unfavourable step	▼ 9%
Equity	€ 250,619 Equity 2022: € 250,619 First fiscal year in the series	€ 280,002 Equity 2023: € 280,002 ▲ 12% vs 2022 (€ 250,619) Favourable step	€ 319,573 Equity 2024: € 319,573 ▲ 14% vs 2023 (€ 280,002) Favourable step	€ 145,693 Equity 2025: € 145,693 ▼ 54% vs 2024 (€ 319,573) Unfavourable step	▼ 54%
Total debts	€ 217,566 Total debts 2022: € 217,566 First fiscal year in the series	€ 219,632 Total debts 2023: € 219,632 ▲ 1% vs 2022 (€ 217,566) Unfavourable step	€ 152,445 Total debts 2024: € 152,445 ▼ 31% vs 2023 (€ 219,632) Favourable step	€ 144,206 Total debts 2025: € 144,206 ▼ 5% vs 2024 (€ 152,445) Favourable step	▼ 5%
Cash	€ 39,544 Cash 2022: € 39,544 First fiscal year in the series	€ 43,442 Cash 2023: € 43,442 ▲ 10% vs 2022 (€ 39,544) Favourable step	€ 43,036 Cash 2024: € 43,036 ▼ 1% vs 2023 (€ 43,442) Unfavourable step	€ 58,182 Cash 2025: € 58,182 ▲ 35% vs 2024 (€ 43,036) Favourable step	▲ 35%
Retained profit	€ 188,619 Retained profit 2022: € 188,619 First fiscal year in the series	€ 218,002 Retained profit 2023: € 218,002 ▲ 16% vs 2022 (€ 188,619) Favourable step	€ 257,573 Retained profit 2024: € 257,573 ▲ 18% vs 2023 (€ 218,002) Favourable step	€ 83,693 Retained profit 2025: € 83,693 ▼ 68% vs 2024 (€ 257,573) Unfavourable step	▼ 68%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 210,000 Dividend 2025: € 210,000 Unchanged (€ 0) Unchanged
Bank debt	€ 94,741 Bank debt 2022: € 94,741 First fiscal year in the series	€ 80,643 Bank debt 2023: € 80,643 ▼ 15% vs 2022 (€ 94,741) Favourable step	€ 66,102 Bank debt 2024: € 66,102 ▼ 18% vs 2023 (€ 80,643) Favourable step	€ 62,319 Bank debt 2025: € 62,319 ▼ 6% vs 2024 (€ 66,102) Favourable step	▼ 6%
Balance sheet total	€ 468,184 Balance sheet total 2022: € 468,184 First fiscal year in the series	€ 499,634 Balance sheet total 2023: € 499,634 ▲ 7% vs 2022 (€ 468,184) Unchanged	€ 472,018 Balance sheet total 2024: € 472,018 ▼ 6% vs 2023 (€ 499,634) Unchanged	€ 289,900 Balance sheet total 2025: € 289,900 ▼ 39% vs 2024 (€ 472,018) Unchanged	▼ 39%
Employees (FTE)	0.7 Employees (FTE) 2022: 0.7 First fiscal year in the series	0.8 Employees (FTE) 2023: 0.8 ▲ 0.1 vs 2022 (0.7) Unchanged	0.6 Employees (FTE) 2024: 0.6 ▼ 0.2 vs 2023 (0.8) Unchanged	0.2 Employees (FTE) 2025: 0.2 ▼ 0.4 vs 2024 (0.6) Unchanged	▼ 0.4

Key figures of APOTHEEK BURMS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to APOTHEEK BURMS?

What happened at APOTHEEK BURMS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 FARMAS NV stepped down as director. NBB
Mar 12, 2026 New annual accounts for financial year 2025: profit of € 36,121 (▼ 9% vs 2024). Source: NBB ↗
2022 FARMAS NV became a director. NBB
Jan 15, 1993 New establishment in Lede. KBO
Oct 14, 1992 Start of the company according to the CBE. KBO

In short

From € 28,666 profit in 2022 to € 36,121 profit in 2025.

Paid € 51,785 in corporate taxes since 2022.

Best year ever: 2024, with € 39,571 profit.

Paid out € 210,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

FARMAS 100%

The stake of FARMAS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK BURMS

The shares are held by FARMAS (100%).

Directors

According to the 2025 annual accounts

FARMAS NV

Director · represented by Lieve Asselman

since 2022 · until 2028

Shareholders

FARMAS

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Markt 35

9340 Lede

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0448.549.180

VAT number

BE 0448.549.180

Registered office

Markt 35, 9340 Lede

Names & denominations

APOTHEEK BURMS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

14 October 1992

Peppol

Active · Active since 9 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK BURMS

Warning lights

Financials

What happened to APOTHEEK BURMS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions